Blue Matter is pleased to announce that Jenna Riffell has joined as a Partner based in London. Jenna officially joined the firm on April 15 and brings a broad base of consulting experience that will ...

Coming from AstraZeneca, where he led multiple commercial functions including four years in charge of AZ Respiratory and GI franchise ... respected events for bio & pharmaceutical manufacturing ...

DB-OTO, which Regeneron obtained from the 2023 acquisition of Decibel Therapeutics for $109 million, works by delivering a ...

Fzata, Inc., a near clinical-stage biotechnology company developing oral biologics for GI disorders, announces it will attend the BIO International Convention 2025 in Boston. The goal is to identify a ...

Over Lars Fruergaard Jørgensen's eight years as CEO, Novo’s sales, profits and share price have almost tripled, the company ...

BioMarin sees growth from Voxzogo but faces competition and product declines. Market pressures lead to a downgrade from Buy ...

Good day, and welcome to Arcutis Biotherapeutics 2025 first-quarter financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now ...

At the moment, Pfizer's Prevnar franchise dominates the child and adult ... Sanofi has expanded its alliance with South Korea-based SK Bio, first signed more than a decade ago, paying an upfront ...

BioMarin Pharmaceutical BMRN reported first-quarter 2025 adjusted earnings per share of $1.13, which beat the Zacks Consensus Estimate of 94 cents. Quarterly earnings rose 59% year over year, driven ...

Shiong, the billionaire cancer drug pioneer and owner of the Los Angeles Times, feels like going back in time five years.

Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call. [Operator Instructions] Also, today's call is being recorded. [Operator Instructions] At this time, ...